Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 3, 2025

November 3, 2025

Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025

GlobeNewswire

November 3, 2025

Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

November 3, 2025

Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

November 3, 2025

Galecto to Highlight GB3226 Program at ASH 2025

GlobeNewswire

November 3, 2025

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss

GlobeNewswire

November 3, 2025

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire

November 3, 2025

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

November 3, 2025

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

GlobeNewswire

November 3, 2025

Flare Therapeutics to Participate in Upcoming Investor Conferences in November

GlobeNewswire

November 3, 2025

NewGen Announces Proposed Reverse Merger with SAXA, Inc. in a $5 Billion Mining Asset Acquisition Deal, Involving Gold, Silver, and Rare Earth

GlobeNewswire

November 3, 2025

BlossomHill Therapeutics to Present at the 67th American Society of Hematology (ASH) Annual Meeting on Design of Phase 1/1b Study of BH-30236, an Oral Macrocyclic CLK Inhibitor, in R/R AML or HR-MDS

GlobeNewswire

November 3, 2025

Solana Company (NASDAQ: HSDT) Releases Investor Update

GlobeNewswire

November 3, 2025

AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue

GlobeNewswire

November 3, 2025

Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

GlobeNewswire

November 3, 2025

Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010

GlobeNewswire

November 3, 2025

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion

GlobeNewswire

November 3, 2025

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025

GlobeNewswire

November 3, 2025

Vatica Health has merged with Cozeva, expanding leadership in value-based care enablement

GlobeNewswire

November 3, 2025

Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

GlobeNewswire

November 3, 2025

CytoDyn Secures $30 Million Commitment from Yorkville Advisors

GlobeNewswire